Detailed Narrative
Q1 FY27 Financial Highlights
NVE Corporation reported a strong first quarter for FY27, with total revenue surging 81% year-over-year to $11 million. This growth was primarily fueled by an 82% increase in product sales and a 53% increase in contract R&D revenue. Net income saw a substantial 79% rise to $6.39 million, translating to $1.32 per diluted share. Profitability metrics were robust, with gross margin expanding to 81.3% (up from 80.6%), operating margin at 66%, pretax margin at 78%, and net margin at 58%.
New Product Launches and R&D Focus
The company launched two new wafer-level chip scale sensors for implantable medical devices, which are approximately one-third the size of conventionally packaged versions. These new sensors feature a unique MRI-safe capability, remaining stable in magnetic fields over 9 Tesla. NVE's R&D strategy is focused on high-value markets such as advanced humanoid robotics, data centers, and AIoT, with ongoing development of more precise sensors for robotics and power-efficient isolators for power conversion.
Market Strategy and Sales Initiatives
NVE actively participated in two major sensor trade shows, Sensors Converge in Silicon Valley and Sensor+ Test in Germany, to promote its products for robotics, AIoT, and power conversion. Management believes these investments will translate into future sales, particularly highlighting robotics as the strongest growing and most promising market due to the low power and precision advantages of NVE's technologies. The company noted new products are being adopted by both existing and new customers.
Leadership Transition and Board Expansion
President and CEO Daniel Baker announced his retirement, effective at the annual meeting in August, with Pete Eames appointed as his successor. Baker will transition to Chairman of the Board, and the Board will expand from five to seven directors, with Pete Eames and Carolyn Valentine joining. This expansion is intended to strengthen corporate governance, building on the company's existing high ISS governance score.
Capacity Expansion and Balance Sheet Strength
NVE completed a two-year multimillion-dollar capacity expansion, which is now being phased into volume production for new products after initial use for R&D. Fixed asset purchases for the quarter were significantly lower at $57,000, compared to $1.06 million in the prior year, reflecting the completion of this expansion. The balance sheet strengthened, with cash plus marketable securities increasing to $43.9 million as of June 30, 2026, and inventories decreasing 6% due to increased product sales.